ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

27
Analysis
Health CareChina
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
Refresh
13 Nov 2015 17:14

Quick Note - Almost at the Finishing Line

Latest Update:Glass Lewis and ISS have advised Wuxi's shareholders to approve the offer from the consortium. We believe Shareholders will vote in...

Share
05 Nov 2015 20:23

Mindray - 2 Steps back 1 Step forward

Mindray Medical International Limited ("Mindray") has announced that it has entered into a definitive Agreement with Excelsior Union Limited...

Share
13 Sep 2015 11:02

Buyout Offer Lowered to US$27/ADS from US$30/ADS

Mindray's management team has lowered its buyout offer by 10% to US$27/ADS, citing 1) the company's recent poor financial performance, 2)...

Share
05 Sep 2015 02:01

A Buyout Offer That Needs Improvement

iKang Healthcare Group, China's largest private preventive healthcare services provider, has received a preliminary proposal from its founder,...

Share
16 Aug 2015 18:22

Best of Smartkarma: The Guest Editor's Cut #22

Welcome to the 22nd Edition of the Smartkarma [Guest] Editor's Cut, a weekly summary of the key themes and ideas of the last week's research on...

Logo
588 Views
Share
x